ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin

Chuangyu Wen(University of Chicago), Junsheng Peng(Sun Yat-sen University)
Cell Death and Disease
October 24, 2019
Cited by 129


Related Papers